Cargando…

Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers

Background. Insulin resistance is associated with higher breast cancer (BC) penetrance in BRCA mutation carriers. Metabolic syndrome (MetS), an insulin resistance syndrome, can be reversed by adhering to the Mediterranean diet (MedDiet). In a dietary intervention trial on BRCA mutation carriers, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruno, Eleonora, Manoukian, Siranoush, Venturelli, Elisabetta, Oliverio, Andreina, Rovera, Francesca, Iula, Giovanna, Morelli, Daniele, Peissel, Bernard, Azzolini, Jacopo, Roveda, Eliana, Pasanisi, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950953/ https://www.ncbi.nlm.nih.gov/pubmed/28741383 http://dx.doi.org/10.1177/1534735417721015

Ejemplares similares

A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers
por: Pasanisi, Patrizia, et al.
Publicado: (2018)

A Mediterranean Dietary Intervention in Female Carriers of BRCA Mutations: Results from an Italian Prospective Randomized Controlled Trial
por: Bruno, Eleonora, et al.
Publicado: (2020)

The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to BRCA1/2 Variant Type
por: Oliverio, Andreina, et al.
Publicado: (2022)

BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers
por: Oliverio, Andreina, et al.
Publicado: (2020)

Physical activity and sleep behaviour in women carrying BRCA1/2 mutations
por: Galasso, Letizia, et al.
Publicado: (2022)

Author Correction: Physical activity and sleep behaviour in women carrying BRCA1/2 mutations
por: Galasso, Letizia, et al.
Publicado: (2022)

Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment
por: Bruno, Eleonora, et al.
Publicado: (2023)

Corrigendum: Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment
por: Bruno, Eleonora, et al.
Publicado: (2023)

First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report
por: Ripamonti, Carla B, et al.
Publicado: (2013)

miRNA deregulation and relationship with metabolic parameters after Mediterranean dietary intervention in BRCA-mutated women
por: De Summa, Simona, et al.
Publicado: (2023)

Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations
por: Azzollini, Jacopo, et al.
Publicado: (2017)

Co-occurrence of Mayer-Rokitansky-Küster-Hauser syndrome and ovarian cancer: A case report and review of the literature
por: Villa, Roberta, et al.
Publicado: (2019)

Analysis of BRCA1 and RAD51C Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer
por: Tabano, Silvia, et al.
Publicado: (2020)

Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies
por: Azzollini, Jacopo, et al.
Publicado: (2017)

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations
por: Colombo, Mara, et al.
Publicado: (2013)

Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer
por: Azzollini, Jacopo, et al.
Publicado: (2019)

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
por: Crippa, Elisabetta, et al.
Publicado: (2014)

Management of Dietary Habits and Diarrhea in Fap Individuals: A Mediterranean Low-Inflammatory Dietary Intervention
por: Maura, Ciniselli Chiara, et al.
Publicado: (2021)

Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
por: Azzollini, Jacopo, et al.
Publicado: (2023)

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
por: Eisen, Andrea, et al.
Publicado: (2008)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022)

Recruitment in randomized clinical trials: The MeMeMe experience
por: Baldassari, Ivan, et al.
Publicado: (2022)

A management system for randomized clinical trials: A novel way to supply medication
por: Cortellini, Mauro, et al.
Publicado: (2019)

Protective Effect of Aerobic Physical Activity on Sleep Behavior in Breast Cancer Survivors
por: Roveda, Eliana, et al.
Publicado: (2016)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014)

Sex Differences in Rest-Activity Circadian Rhythm in Patients With Metabolic Syndrome
por: Mulè, Antonino, et al.
Publicado: (2021)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes
por: Caleca, Laura, et al.
Publicado: (2019)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis
por: Tomasello, G., et al.
Publicado: (2022)

Circulating choline and phosphocholine measurement by a hydrophilic interaction liquid chromatography–tandem mass spectrometry
por: Guerra, Giulia, et al.
Publicado: (2023)

The psychosocial antecedents of the adherence to the Mediterranean diet
por: Carfora, Valentina, et al.
Publicado: (2022)

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)
por: Kiechle, Marion, et al.
Publicado: (2017)

Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review
por: Daniele, A., et al.
Publicado: (2021)

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction
por: Caleca, Laura, et al.
Publicado: (2018)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
por: Silvestri, Valentina, et al.
Publicado: (2016)

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
por: Osorio, A, et al.
Publicado: (2011)

Monitoring Vitamin B(12) in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic Diseases
por: Mastroianni, Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2qm4a86g72c167v58ka2101lap